ArcherDX

ArcherDX, Inc. is a genomics company headquartered in Boulder, Colorado, specializing in the development and commercialization of advanced genetic analysis products. Established in 2013, the company focuses on next-generation sequencing technologies to enhance genetic mutation detection, particularly in oncology. ArcherDX offers a range of research-use-only products, including DNA-based VariantPlex, RNA-based FusionPlex, and ctDNA-based LiquidPlex assays. These products enable laboratories to conduct genomic analyses for therapy optimization and cancer monitoring. Additionally, ArcherDX provides customized assay design services for clinical and biopharmaceutical clients, allowing them to target specific biomarkers and develop new applications. The company aims to deliver actionable genomic information for the treatment of solid tumors, blood cancers, and sarcomas, catering to academic laboratories, biopharmaceutical firms, and contract research organizations. ArcherDX also seeks regulatory approval for various companion diagnostic assays to further support precision medicine initiatives.

James Ashby

Director of Quality Assurance

1 past transactions

Baby Genes

Acquisition in 2019
Baby Genes is a privately held laboratory that specializes in genetic testing, aiming to empower individuals with insights into their health. The laboratory is both CLIA-certified and CAP-accredited, ensuring high standards in its operations. Baby Genes offers a Newborn Panel that tests 100 genes associated with 171 hereditary disorders, enhancing newborn health through supplemental screening. The company's focus is on providing valuable genetic information to help individuals better understand and manage their health.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.